Akt
Akt 相关产品(122)
- GC16366AKT Kinase InhibitorCAS: 842148-40-7纯度: >99.50% / >99.00% / >98.00%
AKT Kinase Inhibitor是一种具有抗肿瘤活性的Akt激酶抑制剂。
- GC17658GuggulsteroneCAS: 95975-55-6纯度: >99.50%
Guggulsterone是一种从植物Commiphora wightii的树脂中提取的植物甾醇。Guggulsterone可以抑制多种肿瘤细胞的生长,并通过下调抗凋亡基因产物(IAP1、xIAP、Bfl-1/A1、Bcl-2、cFLIP和survivin)、调节细胞周期蛋白(如Cyclin D1和c-Myc)、激活半胱氨酸蛋白酶、抑制Akt以及激活JNK来诱导细胞凋亡。
- GC17963CHPG Sodium saltCAS: 1303993-73-8纯度: >99.00%
CHPG 钠盐是一种选择性 mGluR5 激动剂,可通过 BV2 小胶质细胞中的 TSG-6/NF-κB 通路减弱 SO2 诱导的氧化应激和炎症。
- GC19540α-Linolenic AcidCAS: 463-40-1纯度: >98.00% / >99.00% / >99.50%
An essential ω-3 polyunsaturated fatty acid
- GC25638Miransertib (ARQ 092) HClCAS: 1313883-00-9
Miransertib (ARQ 092) HCl is a novel, orally bioavailable and selective AKT pathway inhibitor exhibiting a manageable safety profile among patients with advanced solid tumors.
- GC31536N-Oleoyl glycineCAS: 2601-90-3纯度: >98.00%
A putative substrate for peptidyl glycine α- amidating enzyme
- GC32510Loureirin ACAS: 119425-89-7纯度: >99.50%
Loureirin A is a flavonoid extracted from the red resin of the herbs of Dracaena cochinchinensis, which is known as Dragon's Blood. Loureirin A inhibits platelet activation by an impairment of PI3K/Akt signaling. Loureirin A inhibits Akt phosphorylation.
- GC32794Ipatasertib dihydrochloride (GDC-0068 (dihydrochloride))CAS: 1396257-94-5纯度: >99.00%
A pan-Akt inhibitor
- GC32892PF-AKT400 (AKT protein kinase inhibitor)CAS: 1004990-28-6纯度: >98.00%
PF-AKT400(AKT 蛋白激酶抑制剂)是一种广泛选择性、强效、ATP 竞争性 Akt 抑制剂,对 PKBα 的选择性高出 900 倍; (IC50=0.5 nM) 比 PKA (IC50=450 nM)。
- GC32939Akt1 and Akt2-IN-1CAS: 893422-47-4纯度: >99.00%
Akt1andAkt2-IN-1是一种有效的变构抑制剂,抑制Akt1(IC50=3.5nM)和Akt2(IC50=42nM)。
- GC33010GSK2110183 hydrochlorideCAS: 2070009-64-0纯度: >99.00%
GSK2110183 hydrochloride 是 GSK2110183 的结构类似物。
- GC33135GSK2110183CAS: 1047634-63-8
Afuresertib (GSK2110183) is a potent, orally bioavailable Akt inhibitor with Ki of 0.08 nM, 2 nM, and 2.6 nM for Akt1, Akt2, and Akt3, respectively. Phase 2.
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC16366 | AKT Kinase Inhibitor | 842148-40-7 | >99.50% / >99.00% / >98.00% | |
AKT Kinase Inhibitor是一种具有抗肿瘤活性的Akt激酶抑制剂。 | ||||
| GC16475 | Afuresertib | 1047644-62-1 | >99.50% | |
A pan-Akt inhibitor | ||||
| GC17500 | SU6656 | 330161-87-0 | - | |
SU6656是一种小分子吲哚酮类化合物,可选择性抑制Src、Yes和Fyn激酶活性,IC 50 值分别为0.28μM、0.02μM和0.17μM。 | ||||
| GC17658 | Guggulsterone | 95975-55-6 | >99.50% | |
Guggulsterone是一种从植物Commiphora wightii的树脂中提取的植物甾醇。Guggulsterone可以抑制多种肿瘤细胞的生长,并通过下调抗凋亡基因产物(IAP1、xIAP、Bfl-1/A1、Bcl-2、cFLIP和survivin)、调节细胞周期蛋白(如Cyclin D1和c-Myc)、激活半胱氨酸蛋白酶、抑制Akt以及激活JNK来诱导细胞凋亡。 | ||||
| GC17963 | CHPG Sodium salt | 1303993-73-8 | >99.00% | |
CHPG 钠盐是一种选择性 mGluR5 激动剂,可通过 BV2 小胶质细胞中的 TSG-6/NF-κB 通路减弱 SO2 诱导的氧化应激和炎症。 | ||||
| GC17984 | FPA 124 | 902779-59-3 | >95.00% | |
A cell-permeable Akt inhibitor | ||||
| GC18374 | API-1 | 36707-00-3 | - | |
An Akt inhibitor | ||||
| GC19036 | ARQ-092 | 1313881-70-7 | >99.00% | |
An orally bioavailable pan-Akt inhibitor | ||||
| GC19484 | BAY1125976 | 1402608-02-9 | >99.50% | |
An allosteric inhibitor of Akt1/2 | ||||
| GC19540 | α-Linolenic Acid | 463-40-1 | >98.00% / >99.00% / >99.50% | |
An essential ω-3 polyunsaturated fatty acid | ||||
| GC25638 | Miransertib (ARQ 092) HCl | 1313883-00-9 | - | |
Miransertib (ARQ 092) HCl is a novel, orally bioavailable and selective AKT pathway inhibitor exhibiting a manageable safety profile among patients with advanced solid tumors. | ||||
| GC30582 | Crosstide | 171783-05-4 | - | |
A peptide substrate for Akt | ||||
| GC30770 | LM22B-10 | 342777-54-2 | >98.00% | |
An activator of TrkB and TrkC | ||||
| GC31536 | N-Oleoyl glycine | 2601-90-3 | >98.00% | |
A putative substrate for peptidyl glycine α- amidating enzyme | ||||
| GC32254 | Deltonin | 55659-75-1 | >99.50% | |
Deltonin是从盾叶薯蓣中得到的甾体皂苷,能够抑制ERK1/2和AKT的活化,具有抗肿瘤的活性。 | ||||
| GC32510 | Loureirin A | 119425-89-7 | >99.50% | |
Loureirin A is a flavonoid extracted from the red resin of the herbs of Dracaena cochinchinensis, which is known as Dragon's Blood. Loureirin A inhibits platelet activation by an impairment of PI3K/Akt signaling. Loureirin A inhibits Akt phosphorylation. | ||||
| GC32794 | Ipatasertib dihydrochloride (GDC-0068 (dihydrochloride)) | 1396257-94-5 | >99.00% | |
A pan-Akt inhibitor | ||||
| GC32892 | PF-AKT400 (AKT protein kinase inhibitor) | 1004990-28-6 | >98.00% | |
PF-AKT400(AKT 蛋白激酶抑制剂)是一种广泛选择性、强效、ATP 竞争性 Akt 抑制剂,对 PKBα 的选择性高出 900 倍; (IC50=0.5 nM) 比 PKA (IC50=450 nM)。 | ||||
| GC32939 | Akt1 and Akt2-IN-1 | 893422-47-4 | >99.00% | |
Akt1andAkt2-IN-1是一种有效的变构抑制剂,抑制Akt1(IC50=3.5nM)和Akt2(IC50=42nM)。 | ||||
| GC33010 | GSK2110183 hydrochloride | 2070009-64-0 | >99.00% | |
GSK2110183 hydrochloride 是 GSK2110183 的结构类似物。 | ||||
| GC33130 | Recilisib (Ex-RAD) | 334969-03-8 | >98.00% | |
Recilisib (Ex-RAD)是一种辐射防护剂,可以激活细胞中AKT和PI3K的活性。 | ||||
| GC33135 | GSK2110183 | 1047634-63-8 | - | |
Afuresertib (GSK2110183) is a potent, orally bioavailable Akt inhibitor with Ki of 0.08 nM, 2 nM, and 2.6 nM for Akt1, Akt2, and Akt3, respectively. Phase 2. | ||||
| GC33308 | AKT-IN-1 | 1357158-81-6 | >98.00% | |
AKT-IN-1是一种变构AKT抑制剂,IC50为1.042μM。 | ||||
| GC33357 | K-80003 (TX-803) | 1292821-90-9 | >98.00% | |
K-80003 (TX-803) 是 tRXRα 的有效抑制剂;依赖 Akt 激活和癌细胞生长。 | ||||
